Use of 18F‐fluorodeoxyglucose Positron Emission Tomography to Monitor Disease Activity in Patients With Giant Cell Arteritis on Tocilizumab
Objective The objective of this study was to assess the value of 18F‐fluorodeoxyglucose (FDG)– positron emission tomography (PET) scans to monitor disease activity in patients with giant cell arteritis (GCA) on tocilizumab. Methods Patients with GCA were recruited into a prospective cohort in which...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-02-01
|
| Series: | ACR Open Rheumatology |
| Online Access: | https://doi.org/10.1002/acr2.11797 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|